Research

Research

Behind every treatment that improves human health is a story of discovery.

As one of the largest and highest-quality medical research institutes in the southern hemisphere, we're home to more than 120 research teams across seven key research areas focused on global health priorities.

Discovery Programs

Tackling the big challenges in biomedical research is no longer the domain of a single discipline. Can immunity be used to target cancer? Do stem cells offer hope for treating asthma? Solutions don’t work in isolation and neither do we.

Our Departments

We rank in the top three universities in Australia - and top 40 globally. Explore our Departments to discover why.

Our researchers

Our more than 120 specialised research labs are led by recognised leaders in the biomedical field.

Global Change Program

Monash BDI researchers are world leaders in addressing global health challenges. We investigate how global change affects health and disease.

Organoid Program

Using state of the art technologies we facilitate the development and analysis of organoids to tackle big questions in biomedical research.

Advanced Bioimaging

MAB integrates commercial and in-house developed techniques, custom quantitative analysis, and data visualization to elevate research strategies and methodologies in a collaborative manner.

AI-Protein Design Program

We strive to lead the advancement AI-powered protein design technology through cutting-edge collaborative research that establishes world-leading Australian capacity and capability.

Monash Clinical Biofilms and Medical Device Infections SIG

Our goal is to develop translatable strategies to mitigate “difficult-to-treat” device-related infections and to improve outcomes for patients receiving medical implants.

-

Research news

Celebrating Excellence: Monash Medicine Early Career Research Excellence Program Awardees 2026

Monash University’s Faculty of Medicine, Nursing and Health Sciences is proud to announce the 2026 recipients of the Monash Medicine Early Career Research Excellence Program (ECREP), celebrating an outstanding cohort of Early Career
11 May, 2026 Research

Monash research drives launch of new biotech targeting genetic kidney disease

Monash University researchers are advancing a new therapeutic approach for Autosomal Dominant Polycystic Kidney Disease (ADPKD) through biotechnology company xCystence Bio, supported by a syndicated pre-seed investment.
30 March, 2026 Biomedicine Discovery Institute
Heidi, Research Compliance Officer (blue gloves) at the mitoHOPE Program, and Tegan, mitoHOPE’s clinical embryologist, at work in the mitoHOPE laboratory at Monash University.

The mitoHOPE Program begins pre-clinical research in mitochondrial donation

The mitoHOPE Program recently commenced Maternal Spindle Transfer (MST) at its Monash University laboratory using donated eggs.
11 March, 2026 Biomedicine Discovery Institute
A/Prof Adam Rose and Dr Patricia Rusu

New study reveals how low‑protein diets enhance exercise ability through a surprising energy trade-off

Researchers from Monash University have uncovered how long‑term dietary protein restriction can surprisingly improve weight‑bearing exercise ability - by reshaping how the body budgets energy and activating brown fat thermogenesis.
10 March, 2026 Biomedicine Discovery Institute
Professor Martin Stone and Dr Ram Bhusal, co-lead authors on the study published in Structure

How the canny tick could help prevent disease like MS and cancer

When the immune system detects a harmful or foreign agent it triggers an inflammatory response: small proteins called chemokines direct immune cells to the site of the injury or infection, resulting in the invader being inactivated.
9 March, 2026 Biomedicine Discovery Institute

How CO2-sensing neurons in a worm could eventually protect humans from metabolic stress

All animals, including humans, experience stress. Not the type where you worry about paying bills, but metabolic stress – triggered by starvation, obesity or bacterial infections.
6 March, 2026 Biomedicine Discovery Institute
L-R: Shama Kazmi, MIME MCAP Project Manager, Dr Simon Royce, Dr Paris Papagianis, Professor Jane Bourke and Dr Andrew Carey, MIME Program Manager.

From lab to worksite: how MCAP is accelerating a breakthrough breath test for silicosis

A simple breath test could soon transform how one of Australia’s most devastating occupational lung diseases is detected.
6 March, 2026 Biomedicine Discovery Institute

The trailblazing women working to cure a male disease

At our Prostate Cancer Research Group (PCRG), it’s possible to glimpse a world where gender is no barrier to a successful career in STEM. Here, the women are in charge, even while researching better treatments for a male disease.
6 March, 2026 Biomedicine Discovery Institute

NUS Medicine-Monash study: Intranasal vaccine booster shows stronger immune response and protection against sarbecoviruses

Researchers at the NUS Yong Loo Lin School of Medicine and Monash University have developed a vaccine booster candidate administered via the nasal route, which confers strong immunity in the respiratory tract. The study offers a promising strategy
5 March, 2026 Biomedicine Discovery Institute

More news articles